# K091924: VPS Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Vasonova, Inc.
- Decided: Nov 18, 2009 after 141 days
- Product code: LJS (Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5970
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) VasoNova VPS Catheter: named in the summary without a submission number
- (no number) Bard Catheter: named in the summary without a submission number
- (no number) Medcomp, Catheter: named in the summary without a submission number

## Indications for use
VPs Catheters are indicated Cor short or long-term central or peripheral access to the central venous system for intravenous therapy, central venous pressure monitoring and contrast studies. For blood or hyperalimentation delivery, use a 4F or larger catheter. The maximum recommended injection rate is 2cc/sec for the 3F catheter and 5cc/sec for the 4F and 5F catheters. Each VPS Catheter is indicated for use by itself or with the VPS System (Stylet and Console).

Source page: https://510kreport.com/device/K091924
Methodology: https://510kreport.com/methodology